Literatur
- 01
Alphs LD .
Anand R .
Clozapine: the commitment to patient safety.
J Clin Psychiatry.
1990;
60(suppl 12)
39-42
- 02
Dose M .
Genehmigungspflicht einer Behandlung mit Clozapin nach §1904 des Betreuungsrechtes?.
Nervenarzt.
1994;
65
787-791
- 03
Black LL .
Greenidge LL .
Ehmann T .
et al .
A centralized system for monitoring clozapine use in British Columbia.
Psychiatr Serv.
1996;
47
81-83
- 04
Honigfeld G .
Effects of the clozapine national registry system on incidence of deaths related to
agranulocytosis.
Psychiatr Serv.
1996;
47
52-56
- 05
Honigfeld G .
Arellano F .
Sethi J .
et al .
Reducing clozapine-related morbidity and mortality: 5 years of experience with the
Clozaril National Registry.
J Clin Psychiatry.
1998;
59(suppl 3)
3-7
- 06
Munro J .
O'Sullivan D .
Andrews C .
et al .
Active monitoring of 12.760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.
Br J Psychiatry.
1999;
175
576-580
- 07
Alvir JM .
Lieberman JA .
Safferman AZ .
et al .
Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
N Engl J Med.
1993;
329
162-167
- 08
Alvir M .
Lieberman JA .
Agranulocytosis: incidence and risk factors.
J Clin Psychiatry.
1994;
55,suppl B:
137-138
- 09
Carpenter Jr WT.
Gold JM .
Lathi AC .
et al .
Decisional capacity for informed consent in schizophrenia research.
Arch Gen Psychiatry.
2000;
57
533-538
- 10
Grossman L .
Summers F .
A study of the capacity of schizophrenic patients to give informed consent.
Hosp Community Psychiatry.
1980;
31
205-206
- 11
Schachter D .
Kleinman I .
Prendergast P .
et al .
The effect of psychopathology on the ability of schizophrenic patients to give informed
consent.
J Nerv Ment Dis.
1994;
182
360-362
- 12
Chaplin R .
Timehin C .
Informing patients about tardive dyskinesia: four-year follow up of a trial of patient
education.
Aust N Z J Psychiatry.
2002;
36
99-103
- 13
Deber RB .
Kraetschmer N .
Irvine J .
What role do patients wish to play in treatment decision making?.
Arch Intern Med.
1996;
156
1414-1420
Dr. Egon Michael Haberfellner
Hauptstraße 83-85
4040 Linz Österreich
Email: e.m.haberfellner@aon.at
